Qelby Hesperidin Patch
NDC Package 87369-0001-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Qelby Hesperidin Patch (adhesive silicone gel) patches is ∙Apply the patch to localized areas of pain such as the neck, shoulders, back, arms, legs, knees, chest, abdominal or pelvic areas, etc.∙Replace with a new patch after wearing it continuously for more than 7 days per application∙The effect continues even during bathing or showering.∙Follow the instructions provided on the QR code and in the product manual. This formulation utilizes a patch delivery system. Marketed by Jd Life Sciences Co., Ltd, this product is identified by NDC 87369-0001.

Identification & Billing

NDC Package Code
87369-0001-1
Package Description
1.2 g in 1 PATCH
Product Code
87369-0001
11-Digit Billing Format
87369000101

Clinical Specifications

Proprietary Name
Qelby Hesperidin Patch
Non-Proprietary Name
Adhesive Silicone Gel
Substance Name
Silicon
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SILICON 75 g/100g
Usage Information
∙Apply the patch to localized areas of pain such as the neck, shoulders, back, arms, legs, knees, chest, abdominal or pelvic areas, etc.∙Replace with a new patch after wearing it continuously for more than 7 days per application∙The effect continues even during bathing or showering.∙Follow the instructions provided on the QR code and in the product manual.

Regulatory & Marketing

Labeler Name
Jd Life Sciences Co., Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87369-0001-1 identifies a specific commercial package of 1.2 g in 1 patch of Qelby Hesperidin Patch, a human over the counter drug labeled by Jd Life Sciences Co., Ltd. This patch is formulated for topical use and contains silicon as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jd Life Sciences Co., Ltd on January 01, 2026. The current certification is valid through December 31, 2027.

How is this Jd Life Sciences Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87369000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
87369-0001-1
11-Digit CMS (5-4-2)
87369-0001-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.